Condition: Chronic Cough · Sponsor: Attenua, Inc.
This is a randomized, double-blind, placebo-controlled, crossover, dose escalation study of bradanicline in subjects with chronic cough
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| BioSolutions Clinical Research Center | La Mesa, California, United States | — |
| Allergy & Asthma Associates of Southern California | Mission Viejo, California, United States | — |
| Asthma and Allergy Associates | Colorado Springs, Colorado, United States | — |
| Storms Clinical Research Institute | Colorado Springs, Colorado, United States | — |
| Colorado Allergy and Asthma Center | Denver, Colorado, United States | — |
| Center for Cough | Largo, Florida, United States | — |
| Florida Pulmonary Research Institute | Winter Park, Florida, United States | — |
| Clinical Research Institute | Plymouth, Minnesota, United States | — |
| Mayo Clinic, Pulmonary Clinic Research Unit | Rochester, Minnesota, United States | — |
| Atlantic Research Center, LLC | Ocean Township, New Jersey, United States | — |
| Clinical Research of Gastonia | Gastonia, North Carolina, United States | — |
| National Allergy and Asthma Research | North Charleston, South Carolina, United States | — |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03622216